Date post: | 23-Dec-2015 |
Category: |
Documents |
Upload: | clifton-goodman |
View: | 220 times |
Download: | 1 times |
IP for Scientists
Universities Allied for Essential Medicines (UAEM)
UC Berkeley
Agenda
• Patent law fundamentals• Patenting @ Berkeley• Office of Intellectual
Property & Industry Research Alliances (IPIRA)
• University patenting and global health
• Who we are – UAEM
What is Intellectual Property?
• Intellectual Property (IP): person’s right to have control over the things s/he creates.
• Examples of types of IP
Patent Copyright Trademark
The Balance of IP Law
IP is an attempt to balance between providing financial incentive for innovation and allowing for access to technologies
Access• Allow the public to
use and benefit from the invention
Ownership• Promote research
and protect investments
• Create competition
Patent Law – Give and Take
What you give• A written description of
your invention
• Enablement: disclose how to make and use your invention
• Best mode: disclose the best mode of patenting your invention
What you get• An exclusive right to
exclude others from making, selling, or using your invention for a limited period of time
• The power to assign or license your rights to someone else
What do universities do with patents?
• Licensing: letting a third party use the patented technology under certain conditions– Exclusive license
– Non-exclusive license
Licensor
Licensee
Research Decision to Patent License to Industry
Patenting @ Berkeley
• Office of Intellectual Property & Industry Research Alliances (IPIRA)
• Assistant Vice Chancellor Carol Mimura, Ph.D.
• [Picture of building]
Office of Intellectual Property & Industry Research Alliances (IPIRA)
Office of Technology Licensing (OTL)
Industry Alliances Office (IAO)
• One stop shop for industry-university relations, including sponsored research and intellectual property.
(Assistant Vice Chancellor Carol Mimura )
Contact IPIRA for…
• Disclose an invention
• Material transfer
• Sponsored research agreement
http://otl.berkeley.edu
University Licensing & Global Health: Why Should We Care?
• Gaps in Drug Development Pipeline– Lack of research– Lack of production
• Poor access– High, unaffordable
prices– Lack of adaptive formulations for drugs
• Why? Business profit-based incentives
• Result: Lack of access to life-saving drugs
What can universities do?
• Universities are major players in the drug development field – 40-50% of pharmaceutical industry’s new products rely on academic research.
What can Berkeley do?
• Berkeley - a history of public service– "The distinctive mission of the University is to serve
society as a center of higher learning, providing long-term societal benefits through transmitting advanced knowledge, discovering new knowledge, and functioning as an active working repository of organized knowledge.”
• Socially responsible licensing
Socially Responsible Licensing
• Maximize the social benefit of discoveries made at Berkeley through equitable licensing
• Example policies– Royalty-free license terms for
products sold in developing world– Requirement that licensees provide
low-cost therapies for free or for minimal profit in developing world
– Private-public partnerships
(Peg Skorpinski photo)
Universities Allied forEssential Medicines
• International student organization
• Two-fold Mission– Ensuring access to
life-saving medicines– Promoting research
on neglected diseases• www.essentialmedicine.org• http://uaem.berkeley.edu